Diving Deeper into B2B Social Media Strategies
Despite the fact that the majority of marketing executives surveyed by Accenture acknowledged social media as vital to their companies’ business, only eight percent of B2B compan
What’s in a Word? Plenty, When Used Correctly
A friend recently shared an article from The Economist about why language is not writing and it got me thinking about the subtleties of word selection. A poor word choice in one’
The Scientist is Dead. Long Live The Scientist.
Like many across the life sciences, we were shocked to learn earlier this week that The Scientist – a reading staple of science news and insights for researchers in industry and
Crisis Communications 101: When Saying “Sorry” Isn’t Enough
Even if you haven’t experienced a crisis situation first-hand while working for an organization, you have hopefully at least read your company’s “Crisis Management Plan.” A
Everything Communicates. Even Bacteria.
I’m not new to this marketing gig. I’m really not. Twenty-two years of staying on top of the most effective ways to communicate to prospects had me feeling a little cocky about
Five Things Businesses Must Know About Google+
Build your Personal Profile First, create a personal profile, add some colleagues, and understand how Google+ has integrated parts of Facebook, Twitter, and LinkedIn. Once you feel
Americans & English: Divided by a Common Language
American Independence was declared after the British Parliament insisted on its right to tax American colonists and the Americans claimed their rights as English citizens to no tax
So, You’re a Storyteller
One Christmas Day, early in my career, my grandmother asked what it was that I was doing with myself in that new job of mine. I explained that I was in PR. “Is that like advertis
I’m Anti-Social. Media.
I’m anti-social. There I said it. When it comes to Facebook and Twitter, I can be a bit of an introvert. It’s not that I don’t have much to share. I just don’t have the tim
What Can the Shirley Sherrod Story Tell Us All About Judging the FDA
In June, the FDA sent letters to consumer genotyping companies—the companies that analyze your spit and tell you what diseases you’re most at risk of contracting—telling them